Show simple item record

Comparative efficacy of first-line natalizumab versus IFNb or glatiramer acetate in relapsing MS

dc.contributor.authorSpelman, T.
dc.contributor.authorKalincik, T.
dc.contributor.authorJokubaitis, V.
dc.contributor.authorZhang, A.
dc.contributor.authorPellegrini, F.
dc.contributor.authorWiendl, H.
dc.contributor.authorLechner-Scott, J.
dc.date.accessioned2020-06-21T13:45:28Z
dc.date.available2020-06-21T13:45:28Z
dc.date.issued2015
dc.identifier.issn1352-4585
dc.identifier.issn1477-0970
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14090
dc.description31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- OCT 07-10, 2015 -- Barcelona, SPAINen_US
dc.descriptionLugaresi, Alessandra/0000-0003-2902-5589; Horakova, Dana/0000-0003-1915-0036; Havrdova, Eva Kubala/0000-0002-9543-4359; Belachew, Shibeshih/0000-0003-3976-1950;en_US
dc.descriptionWOS: 000365729400450en_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Comm Treatment & Res Multiple Sclerosisen_US
dc.language.isoengen_US
dc.publisherSage Publications Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleComparative efficacy of first-line natalizumab versus IFNb or glatiramer acetate in relapsing MSen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume21en_US
dc.identifier.startpage258en_US
dc.identifier.endpage259en_US
dc.relation.journalMultiple Sclerosis Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record